173 related articles for article (PubMed ID: 32963027)
1. Critical analysis of the utility of initial pleural aspiration in the diagnosis and management of suspected malignant pleural effusion.
Mercer RM; Varatharajah R; Shepherd G; Lu Q; Castro-Añón O; McCracken DJ; Dudina A; Addala D; Tsikrika S; George V; Banka R; Asciak R; Hassan M; Hallifax R; Bedawi EO; Shute JK; Rahman NM
BMJ Open Respir Res; 2020 Sep; 7(1):. PubMed ID: 32963027
[TBL] [Abstract][Full Text] [Related]
2. Quality Gaps and Comparative Effectiveness of Management Strategies for Recurrent Malignant Pleural Effusions.
Ost DE; Niu J; Zhao H; Grosu HB; Giordano SH
Chest; 2018 Feb; 153(2):438-452. PubMed ID: 28864054
[TBL] [Abstract][Full Text] [Related]
3. Idiopathic Pleural Effusions: Characteristics and Discrimination From Cytology-Negative Malignant Pleural Effusions.
Park JE; Do YW; Lee DH; Lee SY; Lim JK; Choi SH; Seo HW; Yoo SS; Lee SY; Cha SI; Park JY; Lee J; Kim CH
Am J Med Sci; 2020 Sep; 360(3):236-242. PubMed ID: 32423747
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in the diagnosis and management of malignant pleural effusions.
Heffner JE; Klein JS
Mayo Clin Proc; 2008 Feb; 83(2):235-50. PubMed ID: 18241636
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and management of malignant pleural effusions.
Heffner JE
Respirology; 2008 Jan; 13(1):5-20. PubMed ID: 18197908
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity of Initial Thoracentesis for Malignant Pleural Effusion Stratified by Tumor Type in Patients with Strong Evidence of Metastatic Disease.
Grosu HB; Kazzaz F; Vakil E; Molina S; Ost D
Respiration; 2018; 96(4):363-369. PubMed ID: 30016797
[TBL] [Abstract][Full Text] [Related]
7. Procedures Performed during Hospitalizations for Malignant Pleural Effusions: Data from the 2012 National Inpatient Sample.
Fortin M; Taghizadeh N; Tremblay A
Respiration; 2018; 95(4):228-234. PubMed ID: 29414821
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors for and Time to Recurrence of Symptomatic Malignant Pleural Effusion in Patients With Metastatic Non-Small Cell Lung Cancer with EGFR or ALK Mutations.
Schwalk AJ; Ost DE; Saltijeral SN; De La Garza H; Casal RF; Jimenez CA; Eapen GA; Lewis J; Rinsurongkawong W; Rinsurongkawong V; Lee J; Elamin Y; Zhang J; Roth JA; Swisher S; Heymach JV; Grosu HB
Chest; 2021 Mar; 159(3):1256-1264. PubMed ID: 33217413
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and Management of Pleural Transudates.
Ferreiro L; Porcel JM; Valdés L
Arch Bronconeumol; 2017 Nov; 53(11):629-636. PubMed ID: 28641878
[TBL] [Abstract][Full Text] [Related]
10. Current controversies in the management of malignant pleural effusions.
Azzopardi M; Porcel JM; Koegelenberg CF; Lee YC; Fysh ET
Semin Respir Crit Care Med; 2014 Dec; 35(6):723-31. PubMed ID: 25463163
[TBL] [Abstract][Full Text] [Related]
11. [Thoracocentesis for the assessment of lung cancer with pleural effusion].
Martín Díaz E; Arnau Obrer A; Martorell Cebollada M; Cantó Armengod A
Arch Bronconeumol; 2002 Oct; 38(10):479-84. PubMed ID: 12372198
[TBL] [Abstract][Full Text] [Related]
12. Pro-cathepsin D as a diagnostic marker in differentiating malignant from benign pleural effusion: a retrospective cohort study.
Choi H; Ko Y; Lee CY
BMC Cancer; 2020 Aug; 20(1):825. PubMed ID: 32867726
[TBL] [Abstract][Full Text] [Related]
13. Utility of CEA and CA 15-3 measurements in non-purulent pleural exudates in the diagnosis of malignancy: A single-center experience.
Porcel JM; Civit C; Esquerda A; Salud A; Bielsa S
Arch Bronconeumol; 2017 Aug; 53(8):427-431. PubMed ID: 28237067
[TBL] [Abstract][Full Text] [Related]
14. Molecular Testing on Pleural Fluid Samples.
Oh S; Ronaghi R; Cai G
Semin Respir Crit Care Med; 2019 Jun; 40(3):340-346. PubMed ID: 31525809
[TBL] [Abstract][Full Text] [Related]
15. Malignant pleural effusions: management options with consideration of coding, billing, and a decision approach.
Haas AR; Sterman DH; Musani AI
Chest; 2007 Sep; 132(3):1036-41. PubMed ID: 17873197
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and management of malignant pleural effusions.
Fenton KN; Richardson JD
Am J Surg; 1995 Jul; 170(1):69-74. PubMed ID: 7793501
[TBL] [Abstract][Full Text] [Related]
17. Management of malignant pleural effusions.
Sahn SA
Monaldi Arch Chest Dis; 2001 Oct; 56(5):394-9. PubMed ID: 11887496
[TBL] [Abstract][Full Text] [Related]
18. Pre-EDIT: A Randomized Feasibility Trial of Elastance-Directed Intrapleural Catheter or Talc Pleurodesis in Malignant Pleural Effusion.
Martin GA; Tsim S; Kidd AC; Foster JE; McLoone P; Chalmers A; Blyth KG
Chest; 2019 Dec; 156(6):1204-1213. PubMed ID: 31374208
[TBL] [Abstract][Full Text] [Related]
19. Atypical Pleural Fluid Profiles in Tuberculous Pleural Effusion: Sequential Changes Compared with Parapneumonic and Malignant Pleural Effusions.
Kim CH; Lee SY; Lee YD; Yoo SS; Lee SY; Cha SI; Park JY; Lee J
Intern Med; 2016; 55(13):1713-9. PubMed ID: 27374670
[TBL] [Abstract][Full Text] [Related]
20. Investigating unilateral pleural effusions: the role of cytology.
Arnold DT; De Fonseka D; Perry S; Morley A; Harvey JE; Medford A; Brett M; Maskell NA
Eur Respir J; 2018 Nov; 52(5):. PubMed ID: 30262573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
